| Literature DB >> 27964820 |
Reza Mirzaei1, Susobhan Sarkar1, V Wee Yong2.
Abstract
Glioblastoma is an aggressive and incurable primary brain tumor. While the blockade of immune checkpoints leads to reversal of T cell exhaustion in many cancers, the efficacy of this therapy in glioblastoma requires further consideration of the brain microenvironment beyond T cell activity. Neural cells are crucially dependent on glucose for survival, and tumor cells rabidly consume glucose; the glucose-deprived microenvironment further elevates immune checkpoint molecules to benefit tumor growth and exacerbate T cell exhaustion. We review here how immune checkpoints drive exhaustion in T cells while favoring tumor metabolism, and discuss how glucose competition in the unique CNS milieu is an important consideration to improve the outcomes of immune checkpoint blockade in glioblastoma.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27964820 DOI: 10.1016/j.it.2016.11.005
Source DB: PubMed Journal: Trends Immunol ISSN: 1471-4906 Impact factor: 16.687